# SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)
Canonical URL: https://biopharmsignal.com/news/SCYX/scynexis-announces-presentations-highlighting-the-potent-antifungal-activity-of-its-second-generation-fungerp-scy-247-against-drug-resistant-fungi-at-the-inaugural-interdisciplinary-meeting-on-antimicrobial-resistance-and-innovation-imari
Ticker: SCYX
Company: SCYNEXIS
Source: SCYNEXIS
Published: 2026-01-28 13:00 EST
Original Source URL: https://ir.scynexis.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-30 12:00 EST — [SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)](https://biopharmsignal.com/news/SCYX/scynexis-initiates-phase-1-study-of-scy-770-a-novel-ampk-activator-for-the-treat-9e4687ee) — Source: SCYNEXIS
- 2026-05-22 20:15 EST — [SCYNEXIS Announces One-for-Eight Reverse Stock Split](https://biopharmsignal.com/news/SCYX/scynexis-announces-one-for-eight-reverse-stock-split) — Source: SCYNEXIS
- 2026-05-11 20:23 EST — [SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/SCYX/scynexis-reports-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: SCYNEXIS
- 2026-05-07 01:15 EST — [SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/SCYX/scynexis-announces-inducement-awards-under-nasdaq-listing-rule-5635-c-4) — Source: SCYNEXIS
- 2026-03-31 10:45 EST — [SCYNEXIS Announces $40.0 Million Private Placement](https://biopharmsignal.com/news/SCYX/scynexis-announces-40-0-million-private-placement) — Source: SCYNEXIS
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)